Because serum amyloid A (SAA) is directly involved in the pathogenesis of reactive amyloidosis (i.e., AA amyloidosis), it has been suggested that it may be a better marker for disease control and risk of AA amyloidosis than CRP in humans (Elhani et al., 2024). The gene discussed is CRP; the disease is AA amyloidosis.